NYSE:ASPNAspen Aerogels Stock Price, Forecast & News

Aspen Aerogels' stock was trading at $6.50 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, ASPN shares have increased by 11.7% and is now trading at $7.26.
View which stocks have been most impacted by COVID-19.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aspen Aerogels in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Aspen Aerogels.

Aspen Aerogels is scheduled to release its next quarterly earnings announcement on Thursday, October 29th 2020.
View our earnings forecast for Aspen Aerogels.

Aspen Aerogels Inc (NYSE:ASPN) posted its quarterly earnings data on Thursday, July, 30th. The construction company reported ($0.21) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.20) by $0.01. The construction company earned $24.64 million during the quarter, compared to analysts' expectations of $22.60 million. Aspen Aerogels had a negative net margin of 8.97% and a negative return on equity of 19.00%.
View Aspen Aerogels' earnings history.

Aspen Aerogels issued an update on its FY 2020 After-Hours earnings guidance on Thursday, July, 30th. The company provided earnings per share guidance of -0.67--0.55 for the period, compared to the Thomson Reuters consensus estimate of $-0.46. The company issued revenue guidance of $104-110 million, compared to the consensus revenue estimate of $116.7 million.

6 brokers have issued 1-year price objectives for Aspen Aerogels' shares. Their forecasts range from $9.00 to $15.00. On average, they expect Aspen Aerogels' stock price to reach $10.80 in the next twelve months. This suggests a possible upside of 48.8% from the stock's current price.
View analysts' price targets for Aspen Aerogels.

Media headlines about ASPN stock have been trending negative recently, according to InfoTrie. InfoTrie rates the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Aspen Aerogels earned a coverage optimism score of -2.4 on InfoTrie's scale. They also gave media headlines about the construction company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the next several days.
View the latest news about Aspen Aerogels.

Aspen Aerogels saw a increase in short interest in the month of June. As of June 30th, there was short interest totaling 502,500 shares, an increase of 751.7% from the June 15th total of 59,000 shares. Based on an average trading volume of 140,800 shares, the short-interest ratio is presently 3.6 days. Approximately 2.1% of the company's stock are short sold.
View Aspen Aerogels' Short Interest.

Some companies that are related to Aspen Aerogels include Beacon Roofing Supply (BECN), Boise Cascade (BCC), GMS (GMS), Foundation Building Materials (FBM) and Huttig Building Products (HBP).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Aspen Aerogels investors own include Intelsat (I), Bank of America (BAC), Gilead Sciences (GILD), AMC Entertainment (AMC), Fossil Group (FOSL), Apollo Global Management (APO), Associated British Foods (ABF), Chaarat Gold (CGH), China Unicom (Hong Kong) (CHU) and Ciena (CIEN).

Aspen Aerogels trades on the New York Stock Exchange (NYSE) under the ticker symbol "ASPN."

Aspen Aerogels' stock is owned by many different institutional and retail investors. Top institutional investors include Oaktop Capital Management II L.P. (11.06%), Cowen Prime Services LLC (3.04%), Essex Investment Management Co. LLC (1.42%), Russell Investments Group Ltd. (1.38%), Bank of New York Mellon Corp (0.24%) and Greenwood Capital Associates LLC (0.15%). Company insiders that own Aspen Aerogels stock include Donald R Young and Kelley Conte.
View institutional ownership trends for Aspen Aerogels.

ASPN stock was sold by a variety of institutional investors in the last quarter, including California Public Employees Retirement System, Cowen Prime Services LLC, and Essex Investment Management Co. LLC.
View insider buying and selling activity for Aspen Aerogels.

ASPN stock was purchased by a variety of institutional investors in the last quarter, including Oaktop Capital Management II L.P., Bank of New York Mellon Corp, Greenwood Capital Associates LLC, New York State Common Retirement Fund, Ieq Capital LLC, American International Group Inc., UBS Group AG, and Russell Investments Group Ltd..
View insider buying and selling activity for Aspen Aerogels.

Shares of ASPN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of ASPN stock can currently be purchased for approximately $7.26.

Aspen Aerogels has a market capitalization of $194.89 million and generates $139.38 million in revenue each year. The construction company earns $-14,560,000.00 in net income (profit) each year or ($0.60) on an earnings per share basis. Aspen Aerogels employs 295 workers across the globe.

The official website for Aspen Aerogels is www.aerogel.com.

Aspen Aerogels' mailing address is 30 FORBES ROAD BUILDING B, NORTHBOROUGH MA, 01532. The construction company can be reached via phone at 508-691-1111 or via email at [email protected]